NASDAQ:ALLR | Free Cash Flow | Allarity Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.49M$64,000.00-$4.56M
2025-12-31-$3.24M
2025-03-31-$2.69M$0.00-$2.69M
2024-12-31-$3.21M
2024-03-31-$1.4M
2023-12-31-$1.67M
2023-03-31-$3.2M
2022-12-31-$2.45M
2022-03-31-$5.76M
2021-12-31-$4.32M
2021-03-31-$2.57M
2020-12-31-$2.44M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$14.82M$8,000.00-$14.83M
2024-12-31-$17.35M$298,000.00-$17.65M
2023-12-31-$12.75M$0.00-$12.75M
2022-12-31-$16.82M$18,000.00-$16.84M
2021-12-31-$14.89M
2020-12-31-$7.25M$3,000.00-$7.25M